Can we get rid of the bad bits of social media and keep the good? Is it possible to create a more positive social media experience than the one we get from the platforms that dominate the landscape today? In this episode, Elaine Moore asks what the social media platforms of the future should look like, and whether platforms designed for smaller groups of users with shared interests are the way forward.We hear from writer and tech historian Benj Edwards about the BBS era of the early 1990s; University of Massachusetts professor Ethan Zuckerman; Sarah Gilbert, researcher at Cornell University and Reddit moderator; and Jonathan Abrams, partner at 8-Bit Capital and the creator of Friendster.Presented by Elaine Moore. Produced by Edwin Lane and Josh Gabert-Doyon, Executive producer is Manuela Saragosa. Sound design by Breen Turner and Samantha Giovinco. Original music by Metaphor Music. The FT’s head of audio is Cheryl Brumley. Special thanks to Hannah Murphy.Mentioned in this podcast:The Lex Newsletter: Reddit and the API apocalypseDiscord has won over gamers. Now it wants everybody elseReddit stands firm in clash with users as blackout on forums escalatesRead a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare